The muscles from patients with Duchenne muscular dystrophy (DMD) commonly showed a reduced expression of CD82, which suggests that this molecule may play essential roles of SMPC function in the process of muscle degeneration (Alexander et al., 2016). This evidence concerns the gene CD82 and Duchenne muscular dystrophy.